Safety and Efficacy Evaluation of Erbium Treatment

Exclusion Criteria

• •Subjects with active localized or systemic infections.
• •Immunocompromised subjects.
• •Subjects with coagulation disorder.
• •History of skin photo sensitivity disorders, or use of photosensitizing drugs (e.g., tetracycline or sulfa drugs).
• •Pregnant and/or lactating (All female volunteers will be advised about using birth control during the period of study).
• •In the opinion of the trained clinician, subject is unwilling or unable to adhere to all study requirements, including application and follow-up visits.
• •Use of Accutane® within the past 6 months.
• •Subjects with a history of radiation therapy to the treatment area.
• •Subjects with any skin pathology or condition that could interfere with evaluation or with the use of typical ancillary medical treatments or care used before, during or after treatments.
• •Subjects have undergone dermatological procedures (e.g., laser or light treatments) for the treatment of wrinkles, skin resurfacing, or skin rejuvenation in the treatment area within 1 year of study participation.